Shihezi University, and Punjab University,sign an MoU to collaborate in health sciences
Xinjiang:The School of Medicine, Shihezi University, China, and the Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, have formalized a partnership to advance scientific research and academic exchange in health sciences. A Memorandum of Understanding (MoU) was signed to promote collaboration, aligning with global trends in medical innovation, as announced in a press release on Sunday.
Prof. Dr. Wang Yuanzhi, Vice Dean of the School of Medicine, Shihezi University, and Prof. Dr. Moaz ur Rahman, Director of CEMB, signed the MoU during the International Symposium on Veterinary Vaccine and Drug Technology Cooperation Among Belt and Road Countries in Shihezi, Xinjiang. This initiative reflects the shared vision of both institutions to foster innovation in health sciences.
The agreement was facilitated by Prof. Dr. He Cheng from China Agricultural University, whose pivotal efforts bridged the two institutions. Key areas of collaboration include joint research projects, student and researcher exchanges, and the establishment of international conferences and research centers.
This partnership also emphasizes sharing academic data and publications, addressing intellectual property rights, and submitting joint research proposals to national and international organizations. These measures aim to ensure a global impact in advancing health sciences and technology.
For Pakistan, the MoU represents a significant opportunity to enhance its research infrastructure and expand its global scientific footprint. It underscores the country’s commitment to fostering international partnerships in health science and technology.
For China, the collaboration aligns with its broader Belt and Road Initiative goals, emphasizing shared growth through innovation and cooperation with participating countries. The agreement demonstrates China’s proactive approach to addressing global challenges.
The International Symposium, where the MoU was signed, brought together experts from around the world to discuss critical issues in veterinary vaccine and drug technology. It highlighted the role of collaborative efforts in overcoming these challenges and fostering scientific progress.
Set to remain in effect for five years, with options for renewal, this MoU is a testament to the deepening ties between Pakistan and China in science and technology. Both institutions anticipate long-term benefits, not only for their respective nations but also for the global health science community.
